Summary
Invasion, the ability of an epithelial cancer cell to detach from and move through a basement membrane, is a central process in tumour metastasis. Two components of invasion are proteolysis of extracellular matrix and cellular movement through it. A potential promoter of these two processes is thrombin, the serine proteinase derived from the ubiquitous plasma protein prothrombin. Thrombin promotes the invasion of MDA-MB231 breast tumour cells (a highly aggressive cell line) in an in vitro assay. Invasion by MDA-MB436 and MCF-7 cells, less aggressive cell lines, is not promoted by thrombin. Thrombin, added to the cells, is a stimulator of cellular movement; fibroblast-conditioned medium is the chemotaxin. Thrombin-promoted invasion is inhibited by hirudin. Stimulation of invasion is a receptor-mediated process that is mimicked by a thrombin receptor-activating peptide. Thrombin has no effect on chemotaxis in vitro. Thrombin receptor is detectable on the surface of MDA-MB231 cells, but not on the other two cell lines. Introduction of oestrogen receptors into MDA-MB231 cells by transfection with pHEO had no effect on thrombin receptor expression, in the presence or absence of oestradiol. This paper demonstrates that thrombin increases invasion by the aggressive breast cancer cell line MDA-MB231 by a thrombin receptor-dependent mechanism.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Aragay, A. M., Collins, L. R., Post, G. R., Watson, A. J., Feramisco, J. R., Brown, J. H. & Simon, M. I. (1995). G12 requirement for thrombin-stimulated gene expression and DNA synthesis in 1321N1 astrocytoma cells. J Biol Chem 270: 20073–20077.
Arena, C., Quirk, S. M., Zhang, Y. Q. & Henrikson, K. P. (1996). Rat uterine stromal cells: thrombin receptor and growth stimulation by thrombin. Endocrinology 137: 3744–3749.
Azzam, H. S., Arand, G., Lippman, M. E. & Thompson, E. W. (1993). Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85: 1758–1764.
Bae, S. N., Arand, G., Azzam, H. S., Pavasant, P., Torri, J., Frandsen, T. L. & Thompson, E. W. (1993). Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res Treat 24: 241–255.
Brass, L. F. (1995). Issues in the development of thrombin receptor antagonists. Thromb Haemost 74: 499–505.
Brass, L. F., Manning, D. R., Cichowski, K. & Abrams, C. S. (1997). Signaling through G proteins in platelets: to the integrins and beyond. Thromb Haemost 78: 581–589.
Chenard, M. P., O’Siorain, L., Shering, S., Rouyer, N., Lutz, Y., Wolf, C., Basset, P., Bellocq, J. P. & Duffy, M. J. (1996). High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma. Int J Cancer 69: 448–451.
DeMichele, M. A. A. & Minnear, F. L. (1992). Modulation of vascular endothelial permeability by thrombin. Semin Thromb Hemost 18: 287–295.
Duhamel-Clerin, E., Orvain, C., Lanza, F., Cazenave, J. P. & Klein-Soyer, C. (1997). Thrombin-receptor mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells. Arterioscler Thromb Vasc Biol 17: 1931–1938.
Fidler, I. J. & Ellis, L. M. (1994). The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185–188.
Galis, Z. S., Kranzhofer, R., Fenton, I. I. J. W. & Libby, P. (1997). Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17: 483–489.
Garcia, J. G. N., Pavalko, F. M. & Patterson, C. E. (1995). Vascular endothelial cell activation and permeability responses to thrombin. Blood Coag Fibrinol 6: 609–626.
Garcia, M., Derocq, D., Platet, N., Bonnet, S., Brouillet, J. P., Touitou, I. & Rochefort, H. (1997). Both estradiol and tamoxifen decrease proliferation and invasiveness of cancer cells transfected with a mutated estrogen receptor. J Steroid Biochem Mol Biol 61: 11–17.
Gui, G. P. H., Puddefoot, J. R., Vinson, G. P., Wells, C. A. & Carpenter, R. (1997). Altered cell-matrix contact: a prerequisite for breast cancer metastasis?. Br J Cancer 75: 623–633.
Kranzhofer, R., Clinton, S. K., Ishii, K., Coughlin, S. R., Fenton, IIJW & Libby, P. (1996). Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes. Circ Res 79: 286–294.
Maemura, M., Akiyama, S. K., Woods, Jr V. L. & Dickson, R. B. (1995). Expression and ligand binding of a2b1 integrin on breast carcinoma cells. Clin Exp Metastasis 13: 223–235.
McNicol, A. & Gerrard, J. M. (1993). Post-receptor events associated with thrombin-induced platelet activation. Blood Coag Fibrinol 4: 975–991.
Nierodzok, M. L., Bain, R. M., Liu, L. X., Shivji, M., Takeshita, K. & Karpatkin, S. (1996). Presence of the seven transmembrane thrombin receptor on human tumor cells: effect of activation on tumor adhesion to platelets and tumor tyrosine phosphorylation. Br J Haematol 92: 452–457.
Pentecost, B. T. (1998). Expression and estrogen regulation of the HEM45 mRNA in human tumor lines and in the rat uterus. J Steroid Biochem Mol Biol 63: 1–9.
Price, J. T., Bonovich, M. T. & Kohn, E. C. (1997). The biochemistry of cancer dissemination. CRC Crit Rev Biochem Mol Biol 32: 175–253.
Shapiro, S. S. & McCord, S. (1978). Prothrombin. In Progress in Hemostasis and Thrombosis, vol. 4, p. 177. Grune & Stratton: New York
Thompson, E. W., Paik, S., Brunner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torri, J., Donahue, S., Lippman, M. E., Martin, G. R. & Dickson, R. B. (1992). Association of increased basement membrane invasiveness with the absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150: 534–544.
Thompson, E. W., Yu, M., Bueno, J., Jin, L., Maiti, S. N., Palao-Marco, F. L., Pulyaeva, H., Tamborlane, J. W., Tirgari, R. & Wapnir, I. (1994). Collagen-induced MMP-2 activation in human breast cancer. Breast Cancer Res Treat 31: 357–370.
Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M., Park, I. & Chambon, P. (1989). The cloned human estrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 8: 1981–1986.
Vittet, D. & Chevillard, C. (1993). Thrombin interactions with cells of the megakaryocytic lineage. Blood Coag Fibrinol 4: 759–768.
Wojtukiewicz, M. Z., Tang, D. G., Ciarelli, J. J., Nelson, K. K., Walz, D. A., Diglio, C. A., Mammen, E. F. & Honn, K. V. (1993). Thrombin increases the metastatic potential of tumor cells. Int J Cancer 54: 793–806.
Wojtukiewicz, M. Z., Tang, D. G., Ben-Josef, E., Renaud, C., Walz, D. A. & Honn, K. V. (1995). Solid tumor cells express functional ‘tethered ligand’ thrombin receptor. Cancer Res 55: 698–704.
Zacharski, L. R. (1996). Blood coagulation factors in tumor tissue: implications for cancer therapy. In Malignome und Haemostase, Spanuth E (ed.), p. 134. Springer Verlag: Berlin
Zacharski, L. R. & Costantini, V. (1995). Blood coagulation activation in cancer: challenges for cancer treatment. Hamostaseologie 15: 14–20.
Zacharski, L. R., Wojtukiewicz, M. E., Costantini, V., Ornstein, D. L. & Memoli, V. A. (1992). Pathways of coagulation/fibrinolysis activation in malignancy. Semin Thromb Hemost 18: 104–116.
Zacharski, L. R., Memoli, V. A., Morain, W. D., Schaeppl, J. M. & Rousseau, S. M. (1995). Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding. Thromb Haemost 73: 793–797.
Zucker, S., Conner, C., DiMassmo, B. I., Ende, H., Drews, M., Seiki, M. & Bahou, W. F. (1995). Thrombin induces the activation of progelatinase A in vascular endothelial cells. J Biol Chem 270: 23730–23738.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Henrikson, K., Salazar, S., Fenton, J. et al. Role of thrombin receptor in breast cancer invasiveness. Br J Cancer 79, 401–406 (1999). https://doi.org/10.1038/sj.bjc.6690063
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690063
Keywords
This article is cited by
-
Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?
BMC Cancer (2022)
-
Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer
Clinical and Translational Oncology (2020)
-
Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2
Oncogene (2016)
-
Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells
Molecular Cancer (2015)
-
Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellular carcinoma cells depends on ROS formation and RTK transactivation
Journal of Cancer Research and Clinical Oncology (2015)
